| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |